Terms: = Prostate cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Treatment
8 results:
1. Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience.
Satapathy S; Das CK; Aggarwal P; Sood A; Parihar AS; Singh SK; Mittal BR
Prostate; 2023 Feb; 83(2):169-178. PubMed ID: 36259290
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy.
Filon MJ; Gillette AA; Yang B; Khemees TA; Skala MC; Jarrard DF
Prostate; 2022 Dec; 82(16):1547-1557. PubMed ID: 35980831
[TBL] [Abstract] [Full Text] [Related]
3. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
[TBL] [Abstract] [Full Text] [Related]
4. Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, fad & Trp in cancer cells by FLIM.
Wallrabe H; Svindrych Z; Alam SR; Siller KH; Wang T; Kashatus D; Hu S; Periasamy A
Sci Rep; 2018 Jan; 8(1):79. PubMed ID: 29311591
[TBL] [Abstract] [Full Text] [Related]
5. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
[TBL] [Abstract] [Full Text] [Related]
6. Investigation of Mitochondrial Metabolic Response to Doxorubicin in prostate cancer Cells: An NADH, fad and Tryptophan FLIM Assay.
Alam SR; Wallrabe H; Svindrych Z; Chaudhary AK; Christopher KG; Chandra D; Periasamy A
Sci Rep; 2017 Sep; 7(1):10451. PubMed ID: 28874842
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
Wang XS; Zhao F; Fisch MJ; O'Mara AM; Cella D; Mendoza TR; Cleeland CS
Cancer; 2014 Feb; 120(3):425-32. PubMed ID: 24436136
[TBL] [Abstract] [Full Text] [Related]
8. [High PSA and total prostatectomy: specific and overall 10-year survival].
Paul A; Fourmarier M; Cordonnier C; Petit J; Petit J; Saint F
Prog Urol; 2008 May; 18(5):299-303. PubMed ID: 18538275
[TBL] [Abstract] [Full Text] [Related]
